---
title: "Gossamer Bio surges over 10% as Leerink upgrades to Outperform"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294080046.md"
description: "Gossamer Bio jumps over 10% during regular trading after Leerink Partners upgrades the stock to Outperform."
datetime: "2026-07-28T14:10:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294080046.md)
  - [en](https://longbridge.com/en/news/294080046.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294080046.md)
---

# Gossamer Bio surges over 10% as Leerink upgrades to Outperform

Gossamer Bio(GOSS.US) 7 月 28 日盘中急涨，现涨超**10.33%**，现报**0.22**美元。

消息面上，Leerink Partners 将 Gossamer Bio 评级从市场表现上调至跑赢大市。该股盘前交易时段一度飙涨超**40%**，早盘有多家媒体报导其位列医疗保健板块异动个股，股价显著走高。

### Related Stocks

- [GOSS.US](https://longbridge.com/en/quote/GOSS.US.md)

## Related News & Research

- [Gossamer Bio Restructures Debt, Secures Full Control of Lead Drug Candidate](https://longbridge.com/en/news/293964802.md)
- [Gossamer Bio shareholders approved convertible note exchange proposals at special meeting](https://longbridge.com/en/news/293920719.md)
- [Gossamer Bio Announces Final Convertible Notes Exchange Results](https://longbridge.com/en/news/290056187.md)
- [David E. Shaw Discloses Investment at Gossamer Bio with 9.5% Stake](https://longbridge.com/en/news/289530895.md)
- [Gossamer Bio says $18.95 million of 5% convertible notes due 2027 remain after exchange offer](https://longbridge.com/en/news/290049414.md)